TargetMol Chemicals Inc.??? ?? ??? ?????.

?? ?:TargetMol Chemicals Inc.

??:-

???:marketing@targetmol.cn

??:China

? ?? ?:24571

73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177

?? ????

Bivatuzumab		214559-60-1
Enfortumab		1448664-46-7
HA5		2378406-17-6	C15H10O5
Antiviral agent 34		945152-88-5	C29H33N3O2S
P-gb-IN-1		2632874-49-6	C30H28N2O6
LW3		2803367-68-0	C17H12F3N3O
KM02894		116850-74-9	C7H9N3OS2
AP-C2		682793-07-3	C18H16N4S
1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl-		138801-72-6	C23H20N2S
JHU 75528		947696-17-5	C23H21Cl2N5O2
Z16078526		852222-94-7	C18H17N3O4S
LSD1-IN-27		2904571-94-2	C24H25N3
PI3Kδ-IN-16		2766437-35-6	C22H26N6O2
VU534		923509-20-0	C21H22FN3O3S2
Tubulin polymerization-IN-43		2773345-90-5	C17H13F4N3O
a-MSH, amide Acetate(581-05-5 free base)			C77H109N21O19S
Ipamorelin 2 Pivalic acid	??????		C38H49N9O5
Tubulin polymerization-IN-55		2942396-29-2	C22H24N2O4
XPW1		2700286-66-2	C36H39ClFN7O2
ALK-IN-26		2447607-85-2	C24H23NO3S
Antimalarial agent 30		1597425-64-3	C18H11F3N2
Tubulin inhibitor 32		2923531-39-7	C18H19N3O3
CpCDPK1/TgCDPK1-IN-1		1092788-23-2	C18H17N5
KSK94		2566716-07-0	C25H26N4O
PLpro/RBD-IN-1		1282451-83-5	C13H10N4O
Estrogen receptor antagonist 8		2889370-92-5
Zharp2-1		2772600-18-5	C19H18N3O2PS
Aprocitentan	??-132577	1103522-45-7	C16H14Br2N6O4S
PAC1R antagonist 1		2305204-24-2	C17H17ClN6O2
AST 7062601		675197-89-4	C18H15N3O4S
IRG1-IN-1		2407652-42-8	C18H15FO4
QST4		2991427-35-9	C16H13ClN4O2S2
B-Raf IN 16		2304746-24-3	C20H19N5O3S
RN-1665		1803003-65-7	C20H24F5N3O3S2
SARS-CoV-2 3CLpro-IN-16		352659-40-6	C17H14N2OS
h-NTPDase-IN-3		2939933-10-3	C16H10N4S
Aneratrigine hydrochloride		2097163-75-0	C19H20ClF2N5O2S2.ClH
Lingdolinurad		2088176-96-7	C17H12BrN3O2
EGFR/ErbB-2 inhibitor-1		1135150-79-6	C23H15ClFN3OS2
EGFR-IN-87		1835666-87-9	C28H33N7O2
JG-2016		2887480-87-5	C18H21ClN4O3
Topoisomerase II inhibitor 14		305343-00-4	C15H11Cl2N5
3,3'-Selenobisalanine		61216-56-6
KSK67		2566715-93-1	C22H27N3O2
CCG-13514		423741-32-6	C25H25BrN2O2
AKE-72		2566525-18-4	C30H29F3N6O
IR820-PTX		2250419-19-1	C99H112N4O21S2.Na
Cbl-b-IN-5		2368835-59-8	C17H17N5OS
MMP-9-IN-6		2241964-36-1	C25H19NO2
S5A1		2055882-51-2	C27H33N3O4.ClH
Anti-inflammatory agent 51		2911610-03-0	C22H22N6O6S
BCPA		547731-67-9	C22H22Cl2N2O2
(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid		2919211-45-1	C16H23N3O2.C4H6O6
17β-HSD10-IN-1		2316765-78-1	C16H13ClN4O3S
NSC 122393		73654-97-4	C20 H8 Br4 O5
SARS-CoV-2-IN-39		2882823-03-0	C14H8ClF4NO3
Nurr1 agonist 2		742058-34-0	C18H14O3S
SQLE-IN-1		1019169-83-5	C24H21F2N5O2S
(Z)-Tenilapine		82650-82-6	C17H16N4S2
BCAT-IN-4		406190-85-0	C19H14N2O4S
TNF-α-IN-9		2054199-25-4	C17H14O4
MyD88-IN-1		2911609-80-6	C23H24N6O7S
TV 3279		209394-29-6	C16H20N2O2
DSPE-NHS		1383932-86-2	C49H89N2O13P
TIM-3-IN-2		1113126-49-0	C25H23N3O6
h-NTPDase-IN-2		2939933-03-4	C19H16N4S
AMPK activator 12		431920-24-0	C23H24BrNO2
Nrf2 activator-3		2766570-23-2	C23H18F3N3O2
A09-003		2911646-14-3	C23H26N4O
Ogremorphin		352563-21-4	C21H17N3OS
MC4033		28532-21-0	C16H13N3O3
MY-1076		3008262-76-5	C29H33NO9
IDH2R140Q-IN-2		2749568-16-7	C21H18F6N6O
TIE-2/VEGFR-2 kinase-IN-5		1014407-83-0	C21H13F6N5O2
EBOV-IN-1		1335113-30-8	C34H43N3O5
Usenamine A		1428417-60-0	C18H17NO6
DHX9-IN-2		2973395-71-8	C18H16ClN3O3S2
FC-116		2417298-29-2	C21H20FNO4
Enpp-1-IN-16		2289739-47-3	C23H32N4O4
D4R agonist-1		2826198-44-9	C19H22N4S
Phosphatase-IN-1		2889356-55-0	C16H16Cl2FNO2
KSK68		2566715-91-9	C23H28N2O2
SARS-CoV-2-IN-38		2882823-27-8
LFHP-1c		2102347-47-5	C55H64N6O4
ADS032		2757333-37-0	C22H29NO4S
TNF/IFNγ-IN-1		876013-29-5	C20H23N3O6
1-N-Methyl-4-mercaptohistidine disulfide	1-N-??-4-????????????	73491-33-5
AC-099 hydrochloride		849335-07-5	C9H9Cl2F3N4
MoTPS1-IN-1		2991072-02-5	C23H27F3N2O4
Anti-inflammatory agent 49		851471-44-8	C21H22N8O3S
Trontinemab		2568868-35-7
(S)-OSMI 3		2411972-78-4	C32H35N3O9S2
Tenilapine		82650-83-7
A2B receptor antagonist 2 hydrochloride		724-70-9	C12H15N5.ClH
lorvotuzumab		339306-30-8
PLH2058		2525206-41-9
HDAC-IN-57		2716217-79-5	C21H19N3O4
Clivatuzumab		1622075-09-5
DJ4		1681020-24-5	C19H16N4OS
PLH1215		1332084-64-6

午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

TargetMol Chemicals Inc.??? ?? ??? ?????.

?? ????